Bioequivalence and Bioavailability Forum

Hi all,

a quick question:
I believe it is common practice to pull out CMSs from DCPs as long as step II of the procedure has not commenced, i.e. up to the end of the clock-stop. As such I imagine there would be a guideline, directive, best practice, Q&A or procedural commentary document from CMD(h)/HMA's website or somewhere under the Eudralex collection mentioning the issue of revising the list of CMSs, when and how.
Can't find it, though. Any of you experts know where to look?

Many thanks.